Insider Trading April 3, 2026 12:04 PM

A.K.A. Brands Director Disposes of $157,270 in Stock; Company Sales Meet Guidance

Director Ilene Eskenazi trimmed her stake as A.K.A. Brands posts modest sales gains for fiscal 2025

By Avery Klein AKA
A.K.A. Brands Director Disposes of $157,270 in Stock; Company Sales Meet Guidance
AKA

Ilene Eskenazi, a director at A.K.A. Brands Holding Corp (NYSE: AKA), sold 12,201 shares on November 12, 2025, for about $157,270. The sale occurred at prices between $12.28 and $13.655, with a volume-weighted average price of $12.89. After the transaction Eskenazi directly holds 5,852 shares. The sale comes as AKA shares trade at $10.49 and as the company reported fourth-quarter net sales consistent with guidance and a full-year revenue increase driven by U.S. performance.

Key Points

  • Director Ilene Eskenazi sold 12,201 A.K.A. Brands shares on November 12, 2025, for roughly $157,270 at prices between $12.2800 and $13.6550; VWAP reported at $12.89.
  • After the sale Eskenazi directly holds 5,852 shares.
  • A.K.A. Brands reported fourth-quarter net sales of $164 million, a 3.1% increase, and full-year net sales of $600 million, up 4.4%, with results in line with guidance.

Ilene Eskenazi, serving on the board of A.K.A. Brands Holding Corp (NYSE: AKA), disposed of 12,201 shares of the company's common stock on November 12, 2025. The block generated roughly $157,270 in proceeds, with execution prices spanning from $12.2800 to $13.6550 per share. The transactions carry a reported volume-weighted average price of $12.89.

Following the sale, Eskenazi's direct holding in A.K.A. Brands stands at 5,852 shares. The insider transaction coincides with a period in which AKA's market price is lower than those executed sale prices; the stock most recently traded at $10.49.


Market context and stock performance

Over the last 12 months AKA shares have declined 25.6%. Analysis from InvestingPro highlights elevated volatility, noting the stock has traded in a $7.00 to $16.38 range over the past 52 weeks. The company remains unprofitable on a per-share basis, reporting a negative earnings per share of $2.93. Despite the loss, sell-side analysts maintain price targets for AKA that range from $11 to $30.


Company operating results

A.K.A. Brands reported a 3.1% increase in net sales for the fourth quarter of 2025, bringing quarterly revenue to $164 million. Management said this outcome was in line with the firm's guidance. For the full fiscal year, net sales rose 4.4% to $600 million, a gain the company attributes primarily to strength in the U.S. market.

The sales figures aligned with expectations and did not prompt an immediate change in the stock price following the announcement. These reported results give a snapshot of the company's recent revenue trajectory while the firm remains unprofitable on an EPS basis.


What this means

The insider sale, contemporaneous with reported revenue growth that met guidance, reflects a discrete transaction by an individual director. The company-level data available in the public filings and the reported analytics together provide the factual basis for assessing the current state of A.K.A. Brands' market performance and recent insider activity.

Risks

  • Stock volatility - InvestingPro flags high volatility for AKA, with a 52-week trading range of $7 to $16.38, which can affect investor returns and make timing of trades more uncertain.
  • Profitability concerns - The company is unprofitable with a negative EPS of $2.93, which poses earnings risk for shareholders and may influence valuation.
  • Analyst target dispersion - Price targets among analysts range widely from $11 to $30, indicating uncertainty around future valuation and expectations.

More from Insider Trading

Interim CFO of Coda Octopus Sells $28,410 of Stock as Company Posts Better-Than-Expected Q1 Apr 10, 2026 SailPoint Chief Accounting Officer Disposes $82.7K in Stock Amid Price Weakness Apr 10, 2026 Goldman Sachs Executes Market-Making Purchases in Sweetgreen, Acquires $3.3M Stake Apr 9, 2026 Rockwell Automation SVP Executes $484,375 Stock Sale Under 10b5-1 Plan Apr 9, 2026 Relay Therapeutics CFO Disposes $257K in Shares as Stock Trades Near Yearly Peak Apr 9, 2026